Melanoma Update: Yehey for Yervoy!

The drug company Bristol- Myers Squibb has gained approval from the Food and Drug Administration (FDA) for Yervoy (ipilimumab) for the treatment of Melanoma, a very aggressive and often fatal form of cancer which is also the leading cause of death from skin cancer.

Although the complete course of treatment is quite expensive at the moment, we can only hope that in the near future it will become more affordable and be accessible to the majority of the population.

Here's the recent article from the New York Times: Yervoy, a Melanoma Drug, Wins F.D.A. Approval.